A|B|C|D|E|F|G|H|I|J|K|L|M|N|O|P|Q|R|S|T|U|V|W|X|Y|Z|ALL

  检 索： 期刊名称 ISSN         高级检索

期刊名称：LANCET HAEMATOLOGY ISSN： 2352-3026 出版频率： Monthly 出版社： ELSEVIER SCI LTD, THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND, OXON, OX5 1GB   出版社网址： http://www.journals.elsevier.com/the-lancet-haematology/ 期刊网址： http://www.thelancet.com/journals/lanhae/issue/current 影响因子： 18.959 主题范畴： HEMATOLOGY 变更情况： Newly Added by 2015 期刊简介(About the journal)    投稿须知(Instructions to Authors)    编辑部信息(Editorial Board)    About the journal The Lancet Haematology launched in September 2014 as an exclusively online journal, publishing original research, expert commentary, informative editorials, and timely correspondence that advocate a change in, or illuminate, haematological clinical practice. The Lancet Haematology builds on The Lancet journals' reputation for publishing high-impact research and covers the breadth of clinical haematology which includes, but not limited to, the subjects of: haematology-oncology, red and white blood cell disorders, platelet disorders, stem cell transplantation and induced pluripotent stem cells, and transfusion medicine. Following in The Lancet tradition, the journal is stringently edited and peer-reviewed to ensure scientific merit and clinical relevance. All original research is Fast Track peer reviewed for online publication within 8 weeks of submission and receives global exposure to the medical community via our online platforms thelancet.com and ScienceDirect. For selected high-impact research, the journal has a dedicated press office to facilitate worldwide media coverage, ensuring extensive global exposure of your research. Visit www.thelancet.com/haematology for more information. Instructions to Authors The Lancet Haematology: Information for Authors The Lancet Haematology is an exclusively online journal dedicated to publishing original research that advocates change in, or illuminates, haematological clinical practice, including, but not limited to, the subjects of: haematology-oncology, red and white blood cell disorders, platelet disorders, stem cell transplantation and induced pluripotent stem cells, and transfusion medicine. All original research judged eligible for consideration by the journal’s editors will be peer-reviewed within 72 h and, if accepted, published online within 8 weeks from submission. The journal will also publish relevant commentary and correspondence. Wherever possible, figures and good quality photographs (colour or black and white) should be used to supplement and to enhance the text. We also welcome videos. Further details on the different sections of The Lancet Haematology, and how to submit to the journal, are provided below. If you require further clarification, the journal's editorial staff will be pleased to help (email haematology@lancet.com). Manuscripts must be solely the work of the author(s) stated, must not have been previously published elsewhere, and must not be under consideration by another journal. The Lancet journals are signatories of the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, issued by the International Committee of Medical Journal Editors (ICMJE Recommendations), and to the Committee on Publication Ethics (COPE) code of conduct for editors. We follow COPE's guidelines. How to submit your paper Statements, permissions, and signatures Authors and contributors Conflicts of interest Role of the funding source Role of medical writer or editor Patients' consent and permission to publish Signatures Types of article and manuscript requirements Formatting guidelines Guidelines for supplementary material Disclosure of results before publication Online First publication How The Lancet Haematology handles your paper Open access and funding What happens after publication? Download a PDF version of the full guidelines for authors of The Lancet Haematology. LAST UPDATE: March, 2015 Instructions to Authors tlhae-information-for-authors.pdf Editorial Board Editor Lan-Lan Smith